Decisions 13th October 2015


At the meeting that took place on 13th October, the folllowing decisions were agreed.

 

New Drug Requests

Approved

Tiotripium & Olodaterol inhaler (Spoilto) (TLS Bue)

  • Approved for inclusion onto the formulary for maintenance of COPD

Glycopyrronoium (oral) (TLS Amber 3 months)

  • Approved for inclusion onto the formulary for the treatment of hypersalivation in motor neurone disease patients, and in patients with neurological conditions.

Ulipristal (TLS Red)

  • Approved for inclusion onto the formulary for the intermitent treatment of uterine fibroids.
  • SCP in development and when approved will be amber  

 

 

Sodium oxybate

  • The JFG clinically approved the addition of sodium oxybate, however a business case from NBT needs to be submitted to the CCG's for approval before it can be added to the formulary.

 

Shared Care Protocols/TLS Change in Status

Edoxaban

  • NEW SCP approved for the treatment of DVT/PE approved.
     
     

Last updated by: on 05-04-2016 11:45